AlphAIAlphAI — Financial news for AI agents
StockOTC · US · USDHealthcare · Drug Manufacturers - Specialty & Generic

$PTPI

Petros Pharmaceuticals, Inc.

Price · $PTPIvia TradingView
AI sentiment · 7d1 articles
SEP 24net (bullish − bearish)SEP 30
Bullish
0
Neutral
0
Bearish
1
Insider · 30dAll trades →

No SEC Form 4 filings for $PTPI in the last 30 days.

See all $PTPI insider activity →
Top stories · $PTPIMore →
SEP 30·SEC EDGAR 8-KHigh

Petros Pharmaceuticals, Inc. (PTPI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Petros Pharmaceuticals, Inc. (PTPI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 1.03 Bankruptcy or Receivership On September 30, 2026, Petros Pharmaceuticals, Inc. (the “Company”) entered into a General Assignment for the Benefit of Creditors (the “Assignment”), pursuant to California law, in which it assigned all of its right, title, and interest in it

JUN 18·SEC EDGAR 8-K

Petros Pharmaceuticals, Inc. (PTPI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Petros Pharmaceuticals, Inc. (PTPI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 tm2618334d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 GENERAL RELEASE AND SEVERANCE AGREEMENT This General Release and Severance Agreement (the “Agreement”), dated as of June 18, 2026, is made and entered into by and between Mitchell Arnold (“Employee”) and Petros Pharmaceut

JUN 5·SEC EDGAR 8-K

Petros Pharmaceuticals, Inc. (PTPI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Petros Pharmaceuticals, Inc. (PTPI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001815903 0001815903 2026-06-05 2026-06-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Repor

PTPI sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning PTPI (Petros Pharmaceuticals, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

What's driving PTPI

  • The liquidation event triggers immediate redemption of preferred shares and likely forces the common stock to near‑zero value.

    SEC EDGAR 8-K · Sep 30, 2026

  • Director/officer departure with defined severance and equity acceleration; likely modest near-term impact but can affect cash burn and governance optics.

    SEC EDGAR 8-K · Jun 18, 2026

  • The filing discloses a large equity-compensation grant and director/officer appointment/compensation actions, which can affect near-term sentiment and governance optics.

    SEC EDGAR 8-K · Jun 5, 2026

AlphAI scores every news story that mentions PTPI with an AI model for sentiment and relevance, and aggregates insider trades from Petros Pharmaceuticals, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $PTPI

Score
SEP 30$PTPIHighSEC EDGAR 8-K

Petros Pharmaceuticals, Inc. (PTPI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Petros Pharmaceuticals, Inc. (PTPI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 1.03 Bankruptcy or Receivership On September 30, 2026, Petros Pharmaceuticals, Inc. (the “Company”) entered into a General Assignment for the Benefit of Creditors (the “Assignment”), pursuant to California law, in which it assigned all of its right, title, and interest in it

1 min read
JUN 18$PTPILowSEC EDGAR 8-K

Petros Pharmaceuticals, Inc. (PTPI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Petros Pharmaceuticals, Inc. (PTPI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 tm2618334d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 GENERAL RELEASE AND SEVERANCE AGREEMENT This General Release and Severance Agreement (the “Agreement”), dated as of June 18, 2026, is made and entered into by and between Mitchell Arnold (“Employee”) and Petros Pharmaceut

4 min read
JUN 5$PTPILowSEC EDGAR 8-K

Petros Pharmaceuticals, Inc. (PTPI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Petros Pharmaceuticals, Inc. (PTPI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001815903 0001815903 2026-06-05 2026-06-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Repor

2 min read

Related tickers

More in Drug Manufacturers - Specialty & Generic